LSD, MESCALINE AND SEROTONIN INJECTED INTO MEDIAL RAPHE NUCLEUS POTENTIATE APOMORPHINE HYPERMOTILITY

被引:40
作者
FINK, H [1 ]
OELSSNER, W [1 ]
机构
[1] HUMBOLDT UNIV,INST PHARMACOL & TOXICOL,DDR-1080 BERLIN,GER DEM REP
关键词
D O I
10.1016/0014-2999(81)90556-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:289 / 296
页数:8
相关论文
共 28 条
[1]  
AGHAJANIAN GK, 1970, J PHARMACOL EXP THER, V171, P178
[2]  
BENNETT JL, 1975, LIFE SCI, V15, P1935
[3]  
Boarder M R, 1977, Essays Neurochem Neuropharmacol, V2, P21
[4]   DIFFERENTIAL EFFECTS OF CENTRAL SEROTONIN MANIPULATION ON HYPERACTIVE AND STEREOTYPED BEHAVIOR [J].
CARTER, CJ ;
PYCOCK, CJ .
LIFE SCIENCES, 1978, 23 (09) :953-960
[5]   NEUROLEPTIC INTERACTION WITH SEROTONINERGIC-DOPAMINERGIC MECHANISMS IN NUCLEUS ACCUMBENS [J].
COSTALL, B ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (04) :257-259
[6]   SEROTONINERGIC MODULATION OF DOPAMINE RESPONSE FROM NUCLEUS ACCUMBENS [J].
COSTALL, B ;
NAYLOR, RJ ;
MARSDEN, CD ;
PYCOCK, CJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (06) :523-526
[7]   PSYCHOTOMIMETICS POTENTIATE LOCOMOTOR HYPERACTIVITY INDUCED BY DOPAMINERGIC DRUGS [J].
FINK, H ;
MORGENSTERN, R ;
OELSSNER, W .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1979, 11 (05) :479-482
[8]   BEHAVIORAL-STUDIES FOLLOWING LESIONS OF MESOLIMBIC AND MESOSTRIATAL SEROTONERGIC PATHWAYS [J].
GEYER, MA ;
PUERTO, A ;
MENKES, DB ;
SEGAL, DS ;
MANDELL, AJ .
BRAIN RESEARCH, 1976, 106 (02) :257-270
[10]  
GOLD R, 1980, ACTA BIOL MED GER, V39, P917